SCIE期刊CANCER TREATMENT REVIEWS 2024/2025影響因子:9.661 (CANCER TREAT REV) (0305-7372). (ONCOLOGY)(腫瘤學(xué))Science Citation Inde

只看該作者 · 發(fā)表于 2025-3-25 13:19:06

Submitted on: 31 July 2017. Revised on: 21 August 2017. Accepted on: 22 September 2017. ___________________CANCER TREATMENT REVIEWS---ELSEVIER SCI LTD

只看該作者 · 發(fā)表于 2025-3-25 18:27:08

Submitted on: 17 May 2013. Revised on: 05 August 2013. Accepted on: 02 September 2013. ___________________CANCER TREATMENT REVIEWS---ELSEVIER SCI LTD

只看該作者 · 發(fā)表于 2025-3-25 23:10:10

Submitted on: 27 June 1998. Revised on: 18 July 1998. Accepted on: 11 August 1998. ___________________CANCER TREATMENT REVIEWS---ELSEVIER SCI LTD

只看該作者 · 發(fā)表于 2025-3-26 01:02:18

Submitted on: 17 November 2021. Revised on: 09 December 2021. Accepted on: 25 January 2022. ___________________CANCER TREATMENT REVIEWS---ELSEVIER SCI LTD

只看該作者 · 發(fā)表于 2025-3-26 08:21:48

Submitted on: 19 July 1999. Revised on: 07 September 1999. Accepted on: 23 September 1999. ___________________CANCER TREATMENT REVIEWS---ELSEVIER SCI LTD

只看該作者 · 發(fā)表于 2025-3-26 12:09:21

Submitted on: 13 July 2010. Revised on: 28 October 2010. Accepted on: 20 November 2010. ___________________CANCER TREATMENT REVIEWS---ELSEVIER SCI LTD

只看該作者 · 發(fā)表于 2025-3-26 16:07:59

Submitted on: 10 June 2001. Revised on: 31 July 2001. Accepted on: 04 September 2001. ___________________CANCER TREATMENT REVIEWS---ELSEVIER SCI LTD

只看該作者 · 發(fā)表于 2025-3-26 20:36:00

Submitted on: 27 March 2023. Revised on: 04 June 2023. Accepted on: 24 June 2023. ___________________CANCER TREATMENT REVIEWS---ELSEVIER SCI LTD

		自動(dòng)登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛(ài)論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點(diǎn)評(píng)	投稿經(jīng)驗(yàn)總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 16:33
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved